Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Alice Guazzelli, Parisa Meysami, Emyr Bakker, Ezio Bonanni, Constantinos Demonacos, Marija Krstic-Demonacos & Luciano Mutti. (2019) What can independent research for mesothelioma achieve to treat this orphan disease?. Expert Opinion on Investigational Drugs 28:8, pages 719-732.
Read now
Read now
Emyr Bakker, Alice Guazzelli, Firozeh Ashtiani, Constantinos Demonacos, Marija Krstic-Demonacos & Luciano Mutti. (2017) Immunotherapy advances for mesothelioma treatment. Expert Review of Anticancer Therapy 17:9, pages 799-814.
Read now
Read now
Emyr Bakker, Alice Guazzelli, Marija Krstic-Demonacos, Michael Lisanti, Federica Sotgia & Luciano Mutti. (2017) Current and prospective pharmacotherapies for the treatment of pleural mesothelioma. Expert Opinion on Orphan Drugs 5:6, pages 455-465.
Read now
Read now
David Larson, Amy Powers, Jean-Paul Ambrosi, Mika Tanji, Andrea Napolitano, Erin G. Flores, Francine Baumann, Laura Pellegrini, Cormac J. Jennings, Brenda J. Buck, Brett T. McLaurin, Doug Merkler, Cleo Robinson, Paul Morris, Meral Dogan, A. Umran Dogan, Harvey I. Pass, Sandra Pastorino, Michele Carbone & Haining Yang. (2016) Investigating palygorskite’s role in the development of mesothelioma in southern Nevada: Insights into fiber-induced carcinogenicity. Journal of Toxicology and Environmental Health, Part B 19:5-6, pages 213-230.
Read now
Read now
Alice Guazzelli, Michelle Hussain, Marija Krstic-Demonacos & Luciano Mutti. (2015) Tremelimumab for the treatment of malignant mesothelioma. Expert Opinion on Biological Therapy 15:12, pages 1819-1829.
Read now
Read now
Articles from other publishers (10)
Tarun Kumar Patel, Nilanjan Adhikari, Sk. Abdul Amin, Swati Biswas, Tarun Jha & Balaram Ghosh. (2021) Small molecule drug conjugates (SMDCs): an emerging strategy for anticancer drug design and discovery. New Journal of Chemistry 45:12, pages 5291-5321.
Crossref
Crossref
Joëlle S. Nader, Jordan Guillon, Coralie Petit, Alice Boissard, Florence Franconi, Stéphanie Blandin, Sylvia Lambot, Marc Grégoire, Véronique Verrièle, Béatrice Nawrocki-Raby, Philippe Birembaut, Olivier Coqueret, Catherine Guette & Daniel L. Pouliquen. (2020) S100A4 Is a Biomarker of Tumorigenesis, EMT, Invasion, and Colonization of Host Organs in Experimental Malignant Mesothelioma. Cancers 12:4, pages 939.
Crossref
Crossref
Luca Cantini, Raffit Hassan, Daniel H. Sterman & Joachim G. J. V. Aerts. (2020) Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?. Frontiers in Oncology 10.
Crossref
Crossref
Josine M. Quispel-Janssen, Jitendra Badhai, Laurel Schunselaar, Stacey Price, Jonathan Brammeld, Francesco Iorio, Krishna Kolluri, Matthew Garnett, Anton Berns, Paul Baas, Ultan McDermott, Jacques Neefjes & Constantine Alifrangis. (2018) Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition. Clinical Cancer Research 24:1, pages 84-94.
Crossref
Crossref
Daniel L. Pouliquen, Béatrice Nawrocki-Raby, Joëlle Nader, Stéphanie Blandin, Myriam Robard, Philippe Birembaut & Marc Grégoire. (2017) Evaluation of intracavitary administration of curcumin for the treatment of sarcomatoid mesothelioma. Oncotarget 8:34, pages 57552-57573.
Crossref
Crossref
Michele Carbone, Shreya Kanodia, Ann Chao, Aubrey Miller, Anil Wali, David Weissman, Alex Adjei, Francine Baumann, Paolo Boffetta, Brenda Buck, Marc de Perrot, A. Umran Dogan, Steve Gavett, Alessandro Gualtieri, Raffit Hassan, Mary Hesdorffer, Fred R. Hirsch, David Larson, Weimin Mao, Scott Masten, Harvey I. Pass, Julian Peto, Enrico Pira, Ian Steele, Anne Tsao, Gavitt Alida Woodard, Haining Yang & Shakun Malik. (2016) Consensus Report of the 2015 Weinman International Conference on Mesothelioma. Journal of Thoracic Oncology 11:8, pages 1246-1262.
Crossref
Crossref
David Roulois, Sophie Deshayes, Marie-Noëlle Guilly, Joëlle S. Nader, Charly Liddell, Myriam Robard, Philippe Hulin, Amal Ouacher, Vanessa Le Martelot, Jean-François Fonteneau, Marc Grégoire, Christophe Blanquart & Daniel L. Pouliquen. (2016) Characterization of preneoplastic and neoplastic rat mesothelial cell lines: the involvement of TETs, DNMTs, and 5-hydroxymethylcytosine. Oncotarget 7:23, pages 34664-34687.
Crossref
Crossref
Giulia Pinton, Sara Zonca, Arcangela G. Manente, Maria Cavaletto, Ester Borroni, Antonio Daga, Puthen V. Jithesh, Dean Fennell, Stefan Nilsson & Laura Moro. (2016) SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells. Oncotarget 7:12, pages 14366-14379.
Crossref
Crossref
Luciano Mutti. (2015) Malignant pleural mesothelioma: new ideas needed. Lung Cancer Management 4:5, pages 201-203.
Crossref
Crossref
Giulia Pinton, Arcangela G Manente, Antonio Daga, Michele Cilli, Maurizio Rinaldi, Stefan Nilsson & Laura Moro. (2014) Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity. Molecular Cancer 13:1.
Crossref
Crossref